22157.jpg
Worldwide Burn Care Centers Industry to 2028 - Players Include Convatec Healthcare, Coloplast & Acelity Among Others
04 mai 2021 04h33 HE | Research and Markets
Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Burn Care Centers Market Share, Size, Trends, Industry Analysis Report, By Facility Type, By Treatment Type; By Severity; By Service Type; By Regions;...
22157.jpg
Global Burn Care Market (2021 to 2026) - Featuring 3M, Cardinal Health and Medline Industries Among Others
31 mars 2021 05h58 HE | Research and Markets
Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Global Burn Care Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global burn care market is...
Dr. Kaiyo Nedd
RenovaCare Announces Organizational Changes and Appointment of New Officers
30 mars 2021 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare CellMist™ and SkinGun™ System
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
25 févr. 2021 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare CellMist and SkinGun System
RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference
08 janv. 2021 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare 2021 Outlook
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
22 déc. 2020 08h00 HE | RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Intellectual Property Update
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
19 nov. 2020 08h15 HE | RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
22157.jpg
Global Surgical Sealants and Adhesives Market to 2025 by Product, Indication, Application, End User
19 nov. 2020 03h43 HE | Research and Markets
Dublin, Nov. 19, 2020 (GLOBE NEWSWIRE) -- The "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue...
RCAR Press Release Oct 29 2020
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
22 oct. 2020 16h35 HE | RenovaCare, Inc.
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare_FullLogo_RGB-full.png
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
11 août 2020 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...